iOnctura extends series A round to €20 million

iOnctura extends series A round to €20 million

14.07.2020 – iOnctura based at Campus Biotech EPFL Innovation Park has raised an additional EUR 5.1 million bringing its total Series A financing to EUR 20.1 million. New investor 3B Future Health Fund alongside existing international investors, contributed to the round. The funding will enable iOnctura to accelerate the development of its next-generation dual immune and tumour targeting therapies.

read more